Form 4: Select Medical Holdings CFO Receives 75,000 Shares of Restricted Stock
SEC Form 4 Filing
Michael F. Malatesta, CFO of Select Medical Holdings, was granted 75,000 shares of restricted stock on April 30, 2024, which will vest in full on April 30, 2027.
Summary
- On April 30, 2024, Michael F. Malatesta, the Chief Financial Officer of Select Medical Holdings Corporation, received 75,000 shares of common stock.
- These shares were granted as restricted stock.
- The restricted stock will vest in full on April 30, 2027, which is the third anniversary of the grant date, subject to certain exceptions.
- Following this transaction, Malatesta beneficially owns 201,312 shares of Select Medical Holdings Corporation.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of management with shareholder interests. The sentiment is neutral to positive.
Positives
- The grant of restricted stock aligns the CFO's interests with the long-term performance of the company.
- The vesting period of three years suggests a commitment to long-term value creation.
Future Outlook
The vesting of the restricted stock is contingent upon continued service and potentially other performance-based conditions, incentivizing the CFO to contribute to the company's future success.
Industry Context
Grants of restricted stock are a common form of executive compensation in the healthcare industry, aligning management's interests with those of shareholders.
Comparison to Industry Standards
- Executive compensation packages in the healthcare sector often include a mix of salary, bonus, and equity-based awards like restricted stock.
- Companies such as HCA Healthcare and Universal Health Services also utilize restricted stock grants as part of their executive compensation plans.
- The vesting period of three years is fairly standard for restricted stock grants in the industry.
Stakeholder Impact
- Shareholders may view the restricted stock grant as a positive sign, aligning management's interests with the company's long-term success.
- Employees may see this as a positive sign of stability and commitment from the company to its leadership.
Key Dates
| Date | Description |
|---|---|
| 04/30/2024 | Date of the transaction: Grant of restricted stock to Michael F. Malatesta. |
| 04/30/2027 | Vesting date for the restricted stock, subject to certain exceptions. |
| 05/01/2024 | Date of signature of the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.